Ana Maiques – The Future of Non-Invasive Neurotechnology for Epilepsy and Depression
Ana Maiques, MBA, is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate our nerves.
https://www.neuroelectrics.com/blog/author/ana-maiques/
********
BrainMind Special Forum in Neuromodulation/BCI/AI
Ana Maiques, CEO of Neuroelectrics, shares her journey in advancing non-invasive neurotechnology to treat neurological disorders. She introduces the concept of "neuro twins," digital replicas of patients' brains created using MRI and EEG data, enabling personalized and precise treatment planning. Highlighting Neuroelectrics' breakthrough in epilepsy treatment, she discusses how their technology, approved by the FDA, significantly reduced seizures in clinical trials. Maiques also explores their efforts in treating depression, emphasizing the potential to revolutionize psychiatry by targeting specific brain circuits associated with different symptoms. She concludes by celebrating diversity and the dedication of her team in transforming patient care through innovative neurotechnology.
See other talks from this forum: https://www.youtube.com/playlist?list=PL85qrIdmUGCqh988X0Qy3-OcOGXuRmJHI
********
BrainMind is a platform and private community of top brain scientists, entrepreneurs, investors, philanthropists, and academic institutions collaborating to accelerate impactful innovation in brain science.
https://www.brainmind.org/
Apply to become a member of the BrainMind ecosystem:
https://www.brainmind.org/application
Ana Maiques, MBA, is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate our nerves.
https://www.neuroelectrics.com/blog/author/ana-maiques/
********
BrainMind Special Forum in Neuromodulation/BCI/AI
Ana Maiques, CEO of Neuroelectrics, shares her journey in advancing non-invasive neurotechnology to treat neurological disorders. She introduces the concept of “neuro twins,” digital replicas of patients’ brains created using MRI and EEG data, enabling personalized and precise treatment planning. Highlighting Neuroelectrics’ breakthrough in epilepsy treatment, she discusses how their technology, approved by the FDA, significantly reduced seizures in clinical trials. Maiques also explores their efforts in treating depression, emphasizing the potential to revolutionize psychiatry by targeting specific brain circuits associated with different symptoms. She concludes by celebrating diversity and the dedication of her team in transforming patient care through innovative neurotechnology.
See other talks from this forum: https://www.youtube.com/playlist?list=PL85qrIdmUGCqh988X0Qy3-OcOGXuRmJHI
********
BrainMind is a platform and private community of top brain scientists, entrepreneurs, investors, philanthropists, and academic institutions collaborating to accelerate impactful innovation in brain science.
https://www.brainmind.org/
Apply to become a member of the BrainMind ecosystem:
https://www.brainmind.org/application
